Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Non-Current Deffered Revenue (2016 - 2020)

Updated

Argenx Se (ARGX) posted Non-Current Deffered Revenue of -$269.04 billion for Q4 2021, compared with $261.41 billion a year earlier.

Analysis

Argenx Se (ARGX) Non-Current Deffered Revenue (2016 - 2020) Analysis & Trends

Since Q4 2016, Argenx Se has reported Non-Current Deffered Revenue for 8 quarters.

  • In prior years, Argenx Se's Non-Current Deffered Revenue was $269.04 billion in FY2020 (+9.8%), $244.94 billion in FY2019 and $1.62 million in FY2017 (-85.5%).
  • The Q4 2021 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 269.67 Bn
Jun 30, 2020 227.82 Mn
Dec 31, 2019 244.25 Mn
Jun 30, 2019 270.30 Mn
Dec 31, 2017 1.71 Mn
Dec 31, 2016 10.65 Mn
API Access

Argenx Se Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY